Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



AMGEN INC. Stock Hits QuantWave's Price Target Forecast with 16.3% Profit

September 20, 2023
QuantWave, the automated forecasting platform, recently achieved success with its price target forecast for AMGEN INC. stock. The forecast signal was issued on July 25, 2023, indicating a long position with the stock priced at 219.27 $. On September 20, 2023, the target price of 255.01 $ was reached, resulting in a profitable return of 16.3%.

This achievement showcases the accuracy and effectiveness of QuantWave's analytics in predicting stock movements. The successful forecast for AMGEN INC. highlights the platform's ability to provide valuable insights for investors looking to capitalize on market opportunities.

AMGEN INC. is a leading biotechnology company known for its innovative therapies and advancements in healthcare. The stock's movement is influenced by various factors such as drug development, regulatory approvals, and overall market conditions. With QuantWave's sophisticated forecasting algorithms, users gain access to precise predictions that can guide their investment decisions.

QuantWave offers a wide range of stock forecasts, empowering users with valuable information to make informed choices in the dynamic financial markets. For those seeking to enhance their investment strategy, QuantSchool provides comprehensive educational resources on utilizing the QuantWave forecasting system effectively. QuantSchool equips investors with the key principles to generate consistent income and maximize profits in their trading endeavors.
If you want to leave a comment, then you need Login or Register





Other data for AMGN

Related data

AMGNJuly 30, 2025Amgen Inc. NASDAQ:AMGN Shares Unloaded by Rep. Jefferson Shreve  ~1 min.

Recently, Representative Jefferson Shreve unloaded a significant number of Amgen Inc. (NASDAQ:AMGN) shares....


AMGNApril 22, 2025Amgen Inc. AMGN: Among the Innovative Healthcare Stocks to Watch in 2025  ~2 min.

Amgen Inc., a leading biotechnology company, is currently one of the most promising stocks in the healthcare sector....


AMGNMarch 20, 2025Hedge Funds Recommend Amgen Inc. AMGN as the Best Pharma Stock to Buy  ~1 min.

According to recent reports, hedge funds are strongly recommending Amgen Inc. (AMGN) as the best pharma stock to buy....


AMGNMarch 19, 2025Amgen Inc. AMGN: Cutting-Edge Biotech Company Dominates Stock Market  ~2 min.

Amgen Inc. (AMGN), renowned for its groundbreaking innovations in biotechnology, continues to make headlines as a leading player in the stock market....


AMGNMarch 17, 2025Amgen Inc. Continues to Impress Hedge Funds with Strong Performance  ~2 min.

Amgen Inc. (NASDAQ:AMGN) has emerged as the top choice for hedge funds looking to invest in the pharmaceutical sector....


AMGNMarch 16, 2025Amgen Inc. AMGN: Discover Why it's Among the Top Pharma Stocks to Buy  ~2 min.

Amgen Inc., a leading biotechnology company, has been gaining attention in the investment community due to its outstanding performance in the pharmaceutical sector....


AMGNMarch 10, 2025AMGEN INC. Hits Price Target Forecast with 20.7% Profit: A Success Story for QuantWave  ~1 min.

AMGEN INC. has recently reached the price target forecast set by QuantWave, resulting in a significant profit of 20.7% for investors who followed the predictive signal....


AMGNMarch 7, 2025AMGEN INC. Hits Price Target Forecast with 19.78% Profit, as Predicted by QuantWave  ~2 min.

AMGEN INC. (AMGN) recently achieved the price target forecast set by QuantWave, resulting in a profit of 19.78% for investors who followed the prediction....


AMGNFebruary 27, 2025Amgen Inc. AMGN: A Promising Investment Opportunity in the Pharmaceutical Industry  ~2 min.

Amgen Inc. (AMGN), a leading biotechnology company, is regarded as one of the best investment options in the pharmaceutical sector, according to analysts at Yahoo Finance....


AMGNFebruary 26, 2025Amgen Inc. AMGN: Among the Cheap Pharmaceutical Stocks to Buy According to Analysts  ~1 min.

Analysts have identified Amgen Inc. (NASDAQ:AMGN) as one of the cheap pharmaceutical stocks to buy....


BIIBApril 3, 2025Biogen Inc. Hits Price Target Forecast with 10.16% Profit - A Success Story for QuantWave  ~1 min.

Biogen Inc (BIIB) investors recently celebrated a successful price target forecast achievement, thanks to QuantWave's accurate prediction....


AMGNNovember 29, 2024AMGEN TO HOST WEBCAST TO DISCUSS MARITIDE PHASE 2 RESULTS AND PROGRESS ON DEVELOPMENT PROGRAM  ~2 min.

Amgen Inc., a leading biotechnology company, announced today that it will be hosting a webcast to discuss the results of the Maritide Phase 2 clinical trial and provide updates on its development program....


BIIBJanuary 1, 2025Biogen Inc. (BIIB): A Healthcare Stock with Long-Term Value  ~2 min.

Biogen Inc. (BIIB) is a leading biotechnology company that specializes in developing innovative therapies for neurodegenerative diseases....


BIIBDecember 21, 2024Biogen Inc.: A Closer Look at the Healthcare Sector Underperformance  ~2 min.

Biogen Inc., a leading biotechnology company, has been in the spotlight recently due to its underperformance in the healthcare sector....


BIIBOctober 31, 2024Biogen Inc. Hits Price Target Forecast with a Profit of 17.88%  ~2 min.

Biogen Inc. has successfully reached the price target forecasted by QuantWave on October 31, 2024. The forecast signal date was July 30, 2024, with a price of 211.89 $....